|
Q4 FY2026
As of Jun 30, 2026
|
Q3 FY2026
As of Mar 31, 2026
|
Q2 FY2026
As of Dec 31, 2025
|
Q1 FY2026
As of Sep 30, 2025
|
Q4 FY2025
As of Jun 30, 2025
|
Q3 FY2025
As of Mar 31, 2025
|
Q2 FY2025
As of Dec 31, 2024
|
Q1 FY2025
As of Sep 30, 2024
|
Q4 FY2024
As of Jun 30, 2024
|
Q3 FY2024
As of Mar 31, 2024
|
Q2 FY2024
As of Dec 31, 2023
|
Q1 FY2024
As of Sep 30, 2023
|
Q4 FY2023
As of Jun 30, 2023
|
Q3 FY2023
As of Mar 31, 2023
|
Q2 FY2023
As of Dec 31, 2022
|
Q1 FY2023
As of Sep 30, 2022
|
Q4 FY2022
As of Jun 30, 2022
|
Q3 FY2022
As of Mar 31, 2022
|
Q2 FY2022
As of Dec 31, 2021
|
Q1 FY2022
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||||||
| Investment in BCH, at fair value (cost $149,068 and $152,842 as of June 30, 2026 and 2025, respectively) | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Sponsor's Fee payable, related party | ||||||||||||||||||||
| Sponsor | ||||||||||||||||||||
| Total sponsor's Fee payable, related party | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Net assets | ||||||||||||||||||||
| Shares issued and outstanding, no par value (unlimited Shares authorized) | ||||||||||||||||||||
| Principal Market NAV per Share | ||||||||||||||||||||
| Net assets: | ||||||||||||||||||||
| Paid-in-capital | ||||||||||||||||||||
| Accumulated net investment loss | ||||||||||||||||||||
| Accumulated net realized loss on investment in BCH | ||||||||||||||||||||
| Accumulated net change in unrealized appreciation (depreciation) on investment in BCH | ||||||||||||||||||||
Loading...
